This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Trinity Biotech Surges Again

Shares in Trinity Biotech (TRIB - Get Report) surged for a second day Tuesday, after the company's announcement Monday that it had received Food and Drug Administration approval to market its low-cost HIV test in the U.S.

Recently, shares were up another $1.02, or 20%, to $6.16, following a 57% gain Monday.

The company said its Uni-Gold Recombigen test, which is already in use in South Africa, yields results in 10 minutes.

The company also said its product is the only one capable of detecting antibodies to HIV in human blood serum, plasma and whole blood.

The Dublin, Ireland-based company specializes in test kits for the detection of diseases and will sell the testing device directly to hospitals and physicians.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
TRIB $15.92 0.13%
AAPL $125.16 -0.51%
FB $78.49 1.20%
GOOG $529.72 -0.20%
TSLA $231.50 -0.62%

Markets

DOW 17,864.61 -63.59 -0.35%
S&P 500 2,083.39 -6.07 -0.29%
NASDAQ 4,926.4620 -12.8650 -0.26%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs